LOADING
Comparing Merck & Company (MRK) and Intel Corporation (INTC) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | INTC |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $356.0B | $630.8B |
| P/E Ratio | 114.5 | -- |
| Forward P/E | 15.3 | 63.3 |
| PEG Ratio | 2.71 | 0.50 |
| EPS | $1.26 | $-2.09 |
| Revenue Growth (YoY) | 5.1% | 25.4% |
| Profit Margin | 4.8% | -19.8% |
| Return on Equity | 7.0% | -10.7% |
| Dividend Yield | 2.31% | -- |
| Beta | 0.23 | 2.23 |
| 52-Week High | $156.00 | $142.35 |
| 52-Week Low | $79.67 | $32.89 |
| Volume | -- | -- |
Intel Corporation is the larger company by market capitalization. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.